Kenvue Inc. reported fourth‑quarter 2025 results that exceeded analyst expectations, delivering adjusted earnings per share of $0.27 versus the consensus estimate of $0.22—a beat of $0.05 per share. Revenue rose 3.2% year‑over‑year to $3.78 billion, driven by 1.2% organic sales growth and a 2.1% foreign‑currency benefit, and beating the $3.75 billion consensus estimate by roughly $70 million.
The company’s operating‑income margin improved to 14.2% from 13.2% a year earlier, while the adjusted operating margin climbed to 19.9% from 19.2%. Compared with Q4 2024, where adjusted EPS was $0.26 and revenue was $3.66 billion, the current quarter shows a clear acceleration in profitability and top‑line growth. The margin expansion reflects disciplined cost controls, pricing power, and a favorable mix shift across the Self Care, Skin Health & Beauty, and Essential Health segments.
Segment‑level analysis shows that Essential Health net sales increased 6.1% in Q4 2025, driven by 4.2% organic growth, while the Self Care and Skin Health & Beauty segments benefited from subdued seasonal incidences and a rebound in Asia Pacific go‑to‑market activity. These drivers helped offset volume declines and inventory reductions, supporting the company’s overall earnings performance.
Kenvue also announced a global workforce reduction of about 3.5%, expected to generate roughly $250 million in restructuring charges in fiscal 2026. The cuts are part of the “Our Vue Forward” plan, aimed at optimizing the operating model ahead of integration with Kimberly‑Clark and are expected to strengthen cost discipline and operational leverage.
The company will not provide forward guidance because the pending acquisition by Kimberly‑Clark has received shareholder approval and cleared U.S. antitrust waiting requirements. The acquisition is expected to close in the second half of 2026, positioning Kenvue to create a larger, more diversified health‑and‑wellness entity.
Investors responded positively to the earnings beat and the progress on the Kimberly‑Clark deal, citing the company’s strong execution, margin expansion, and the strategic value of the merger as key drivers of the market reaction.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.